⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplemental Table 5 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas

Ming Yu Kelly Carter Kelsey K. Baker Mary W. Redman Ting Wang Kathy Vickers Christopher I. Li Stacey A. Cohen Mukta Krane Jennifer Ose Biljana Gigic Jane C. Figueiredo Adetunji T. Toriola Erin M. Siegel David Shibata Martin Schneider Cornelia M. Ulrich Lynda Dzubinski Robert E. Schoen William M. Grady

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplemental Table 5: Summary statistics for methylated EVL measurements in Comparison Set 1

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yu et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522cbf https://doi.org/10.1158/1055-9965.27029635

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table 5 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
2Supplemental Table 6 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
3Supplemental Table 6 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
4Supplemental Table 7 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
5Supplemental Table 7 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
6Supplemental Table 2 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
7Supplemental Table 2 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024
8Supplemental Table 3 from Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas2024